| 5.4 0.06 (1.12%) | 09-21 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.84 | 1-year : | 7.38 |
| Resists | First : | 5.85 | Second : | 6.32 |
| Pivot price | 5.33  |
|||
| Supports | First : | 5.09 | Second : | 4.24 |
| MAs | MA(5) : | 5.32  |
MA(20) : | 5.51 |
| MA(100) : | 5.53 |
MA(250) : | 5.08 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 26.8 |
D(3) : | 20.4 |
| RSI | RSI(14): 47.2 |
|||
| 52-week | High : | 6.5 | Low : | 3.95 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ SRTA ] has closed below upper band by 35.2%. Bollinger Bands are 54.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 5.47 - 5.51 | 5.51 - 5.54 |
| Low: | 5.25 - 5.29 | 5.29 - 5.32 |
| Close: | 5.35 - 5.41 | 5.41 - 5.46 |
Strata Critical Medical, Inc. is dedicated to supporting healthcare providers throughout the United States by offering swift logistical management and specialized medical assistance. A significant part of their operations involves the movement of human organs for transplant, utilizing both aerial and ground transportation methods. Founded in 2014, the organization previously operated under the name Blade Air Mobility, Inc. and is set to officially change its name to Strata Critical Medical, Inc. in August of 2025. Its primary corporate office is located in New York, New York.
Sat, 19 Sep 2026
Can Strata Critical Medical, Inc. (SRTA) Run Higher on Rising Earnings Estimates? - Eastern Progress
Fri, 18 Sep 2026
Strata Critical Medical, Inc. (NASDAQ: SRTA) Share Price, SRTA Stock News, SRTA Share Price & Updates - kalkine.com.au
Wed, 16 Sep 2026
Strata Critical Medical: Pivot To M&A Offers Near-Term Upside, But TAM Constraints Remain - Seeking Alpha
Thu, 10 Sep 2026
Strata Critical (SRTA) CEO has 5.7K shares withheld for taxes - Stock Titan
Thu, 10 Sep 2026
Strata Critical Medical (SRTA) withholds 31,671 insider shares for taxes - Stock Titan
Tue, 08 Sep 2026
A healthcare conference presentation is set for Sept. 14. Strata Critical Medical will present. - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 88 (M) |
| Shares Float | 58 (M) |
| Held by Insiders | 14.2 (%) |
| Held by Institutions | 71.7 (%) |
| Shares Short | 4,190 (K) |
| Shares Short P.Month | 4,330 (K) |
| EPS | -0.29 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.16 |
| Profit Margin | 15.7 % |
| Operating Margin | -6.4 % |
| Return on Assets (ttm) | -1.9 % |
| Return on Equity (ttm) | -9.3 % |
| Qtrly Rev. Growth | 60.7 % |
| Gross Profit (p.s.) | 0.61 |
| Sales Per Share | 2.89 |
| EBITDA (p.s.) | 0.08 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -36 (M) |
| Levered Free Cash Flow | -20 (M) |
| PE Ratio | -19.29 |
| PEG Ratio | 0 |
| Price to Book value | 1.7 |
| Price to Sales | 1.86 |
| Price to Cash Flow | -13.26 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|